Page last updated: 2024-08-24

ethinylestradiol-3-sulfate and Cancer of Prostate

ethinylestradiol-3-sulfate has been researched along with Cancer of Prostate in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	12 (92.31)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (7.69)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böhm, WD; Geissler, W; Gorski, J; Illig, HD; Koch, R	1
Bär, CM; Dörner, G; Fröhlich, G; Schnorr, D; Stahl, F	1
Dörner, G; Guddat, HM; Rohde, W; Schnorr, D; Stahl, F	2
Fiedler, R; Klebingat, KJ; Lorenz, G; Panzig, E; Steinhauser, I	1
Guddat, HM; Schnorr, D; Zemke, F	1
Dörner, G; Guddat, HM; Rhode, W; Schnorr, D; Stahl, F	1
Drawz, B; Drawz, G; Hoffmann, L; Russbüldt, R	1
Schott, H; Zade, W	1
Sladczyk, E	1
Dörner, G; Rohde, W; Schnorr, D; Stahl, F	2
Miyazawa, Y; Nakano, K; Nakata, S; Sasaki, Y; Takahashi, H	1

Trials

3 trial(s) available for ethinylestradiol-3-sulfate and Cancer of Prostate

Article	Year
[Clinical value of ethinyl estradiol sulfonate (Turisteron)--long-term results of a randomized compound study]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Aged; Clinical Trials as Topic; Combined Modality Therapy; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Neoplasm Staging; Palliative Care; Prostatic Neoplasms; Random Allocation	1987
[Cellular immunity in prostatic cancer modified by Cytonal, Estrazyt and Turisteron]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Aged; Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Estramustine; Ethinyl Estradiol; Humans; Immunity, Cellular; Macrophages; Male; Middle Aged; Nitrogen Mustard Compounds; Prostatic Neoplasms; Random Allocation	1987
[Initial results of a phase IV multicenter clinical trial of Turisteron in the treatment of prostate cancer]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Combined Modality Therapy; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms	1987

Other Studies

10 other study(ies) available for ethinylestradiol-3-sulfate and Cancer of Prostate

Article	Year
Suppression of plasma androgen levels with a combination therapy of depot-estrogen (Turisteron) and Dexamethasone in patients with prostatic cancer. Experimental and clinical endocrinology, 1989, Volume: 94, Issue:3 Topics: Aged; Aged, 80 and over; Androgens; Dexamethasone; Drug Therapy, Combination; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms	1989
[Conservative therapy of prostate cancer using Turisteron]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Ethinyl Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Testosterone	1987
[Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:12 Topics: Ethinyl Estradiol; Follicle Stimulating Hormone; Follow-Up Studies; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone	1987
[Clinical study of ethinyl estradiol sulfonate in conservative therapy of prostate cancer]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Combined Modality Therapy; Drug Implants; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone	1987
[Experiences in the treatment of advanced prostatic cancer using Turisteron with special reference to cardiovascular complications]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma; Cardiovascular Diseases; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk	1987
[Liver damage in hormone therapy of prostate cancer]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Diethylstilbestrol; Ethinyl Estradiol; Humans; Liver Function Tests; Male; Middle Aged; Prostatic Neoplasms	1987
[Clinical experience using Turisteron in the treatment of prostatic cancer]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Aged; Drug Resistance; Ethinyl Estradiol; Humans; Male; Prognosis; Prostatic Neoplasms	1987
[Inhibition of the free, biologically active testosterone level by Turisteron in patients with prostate cancer]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Delayed-Action Preparations; Diethylstilbestrol; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Sex Hormone-Binding Globulin; Testosterone	1987
Successful treatment of prostatic cancer with the orally active depot estrogen ethinylestradiol sulfonate (Turisteron). Experimental and clinical endocrinology, 1985, Volume: 86, Issue:2 Topics: Aged; Delayed-Action Preparations; Ethinyl Estradiol; Gonadotropin-Releasing Hormone; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Testosterone	1985
[Prognostic factors for estrogen therapy of relapsed prostate cancer after maximal androgen blockade (MAB)]. Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2010, Volume: 101, Issue:4 Topics: Aged; Androgen Antagonists; Combined Modality Therapy; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Estrogens; Ethinyl Estradiol; Humans; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Survival Rate; Time Factors	2010